可解释性
人工智能
计算机科学
标杆管理
机器学习
深度学习
图形
药品
计算生物学
精密医学
个性化医疗
相似性(几何)
临床实习
药物重新定位
药物开发
过程(计算)
药物靶点
钥匙(锁)
药物发现
药物基因组学
机制(生物学)
数据挖掘
边距(机器学习)
作者
Jiyin Lai,Jiashuo Wu,Yalan He,Yongbao Zhang,Bin Li,Tingyu Shi,Junwei Han
标识
DOI:10.1038/s41746-026-02830-z
摘要
Tumor heterogeneity and drug resistance limit single-agent therapies, making combination treatments essential. However, traditional screening methods are costly and inefficient. Here, we present DSimSynergy, a graph deep learning framework for predicting drug synergy. It constructs drug similarity networks from biological process and clinical applications, then learns drug representations through graph convolution on these networks. Subsequently, it combines them with graph attention representations of drug molecular fingerprints and cell line gene expressions to predict synergy scores for drug combinations. Comprehensive benchmarking on multiple independent datasets demonstrates that DSimSynergy consistently outperforms state-of-the-art methods. Model interpretability analysis revealed key genes and pathways underlying drug synergy, while validation on clinical patient and cohort data demonstrated good clinical translational potential and discovered the molecular mechanisms by which drugs generate synergistic effects through "pathway complementary networks". DSimSynergy efficiently identifies synergistic combinations, reducing experimental costs while elucidating biological mechanisms to overcome resistance and guide personalized treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI